Related Experiment Video
Updated: Jun 24, 2026

11:01
Moderate Prenatal Alcohol Exposure and Quantification of Social Behavior in Adult Rats
Published on: December 14, 2014
Maternal relaxin concentrations in diabetic pregnancy
B G Steinetz1, P G Whitaker, J R Edwards
1Laboratory for Experimental Medicine and Surgery in Primates, NYU Medical Center, Tuxedo.
Lancet (London, England)
|September 26, 1992
Summary
Maternal serum relaxin concentrations are higher in diabetic pregnancies compared to non-diabetic ones. This elevation is not linked to diabetic control, and its impact on fetal anomalies requires further study.
Area of Science:
- Reproductive biology
- Endocrinology
- Maternal-fetal medicine
Background:
- Relaxin, an insulin homologue, is produced during pregnancy.
- Relaxin levels decrease from the first to the third trimester.
- Previous research suggested higher relaxin in diabetic pregnancies.
Purpose of the Study:
- To compare maternal serum relaxin concentrations in diabetic versus non-diabetic pregnancies.
- To investigate the relationship between elevated relaxin and diabetic control.
- To explore the potential role of relaxin in pregnancy complications.
Main Methods:
- Maternal serum samples collected throughout pregnancy.
- Quantification of relaxin levels.
- Comparison between insulin-dependent diabetic mothers and non-diabetic controls.
Main Results:
- Significantly higher maternal serum relaxin concentrations were observed at all pregnancy stages in diabetic mothers.
- Elevated relaxin levels were independent of diabetic control indices.
- No correlation found between relaxin levels and other markers of diabetic management.
Conclusions:
- Diabetic pregnancies exhibit elevated maternal serum relaxin.
- The physiological significance of higher relaxin in diabetic pregnancies is unknown.
- Further research is needed to determine if relaxin contributes to fetal anomalies in diabetic mothers.
More Related Videos
Related Concept Videos
Glucose Transporters
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Complications of Diabetes Mellitus
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...

